US › Healthcare

MAIA Biotechnology Inc. (MAIA)

US · Healthcare · Biotechnology

$1.36+3.03%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-6.4M

Profit YoY

-41.0%

EPS

$-0.14

EPS estimate

$-0.18

EPS came in at -0.14 against a street estimate of -0.18 — a beat of 22.2%.

Key statistics

Market cap

$80.3M

Forward P/E

0.0

P/B

2.74

Book value

$0.46

EPS (TTM)

$-0.68

52-week high

$3.19

52-week low

$0.87

50-day MA

$1.35

200-day MA

$1.46

Beta

0.25

Analyst view

Analysts rate MAIA Biotechnology Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.13.

Shareholding

Insiders

14.39%

Institutions

21.68%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MAIA Biotechnology Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.